The Study of Immunotherapy With Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Adult Patients With Persistent and Chronic Immune Thrombocytopenia

Trial Profile

The Study of Immunotherapy With Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Adult Patients With Persistent and Chronic Immune Thrombocytopenia

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 07 Feb 2017

At a glance

  • Drugs Dexamethasone (Primary) ; Mycophenolate mofetil (Primary) ; Rituximab (Primary)
  • Indications Immune thrombocytopenic purpura
  • Focus Therapeutic Use
  • Most Recent Events

    • 31 Jan 2017 Planned initiation date changed from 1 Jun 2016 to 1 Jun 2019.
    • 11 Jan 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top